The following studies have recently been activated for patient enrollment by the University of Illinois Cancer Center Clinical Trials Office (CTO). Please click on the link to learn about the details regarding the study on clinicaltrials.gov. For more information or questions about a study, please email firstname.lastname@example.org or call 312-355-5112.
INCB53914-102: A Phase 1b, Multicenter, Open-Label Study of the Safety and Tolerability of INCB053914 in Combination With INCB050465 in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sponsor: Incyte Corporation
Principal Investigator: John Galvin, MD
Sponsor: Big Ten Cancer Research Consortium
Principal Investigator: John Quigley, MD